Company news
Brain Biotech Ag (XETR:BNN) news
Every Brain Biotech Ag press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma
September 9, 2026
Dr. Sven K. Weber Succeeds Adriaan Moelker as CEO of BRAIN Biotech AG
July 29, 2026
BRAIN Biotech AG signs new Revolving Credit Facility with MP Beteiligungs-GmbH
July 13, 2026
BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance
May 28, 2026
BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
March 23, 2026
Results of the 2026 Annual General Meeting for the 2024/25 Financial Year of BRAIN Biotech AG
March 11, 2026
BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase® Wound Gel showing strong clinical ev...
February 25, 2026
BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evi...
February 25, 2026
FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control
January 14, 2026
BRAIN Biotech AG Appoints Johan Jansen-Storbacka as Executive Vice President of the BRAINBiocatalysts' Enzyme Products Business
September 3, 2025
BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts
August 28, 2025
BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
May 28, 2025
BRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Center
May 20, 2025